SEBASTIANI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.760
EU - Europa 26.445
AS - Asia 15.692
SA - Sud America 2.172
Continente sconosciuto - Info sul continente non disponibili 683
AF - Africa 396
OC - Oceania 126
Totale 78.274
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.923
IT - Italia 15.139
SG - Singapore 4.618
GB - Regno Unito 4.242
CN - Cina 4.106
HK - Hong Kong 1.776
BR - Brasile 1.606
VN - Vietnam 1.491
SE - Svezia 1.334
DE - Germania 934
FR - Francia 925
BD - Bangladesh 884
FI - Finlandia 835
UA - Ucraina 662
RU - Federazione Russa 580
NL - Olanda 541
KR - Corea 538
TR - Turchia 524
CA - Canada 386
IN - India 370
JP - Giappone 299
ID - Indonesia 291
MX - Messico 255
BG - Bulgaria 248
IE - Irlanda 206
AR - Argentina 193
PL - Polonia 134
ZA - Sudafrica 130
AU - Australia 115
IQ - Iraq 113
PK - Pakistan 96
CH - Svizzera 90
EC - Ecuador 87
ES - Italia 86
AE - Emirati Arabi Uniti 77
MY - Malesia 75
CL - Cile 72
LT - Lituania 72
CO - Colombia 69
TN - Tunisia 66
BE - Belgio 64
RO - Romania 58
SA - Arabia Saudita 58
AT - Austria 56
VE - Venezuela 50
PH - Filippine 49
EG - Egitto 48
IR - Iran 41
MA - Marocco 38
TH - Thailandia 36
BZ - Belize 32
NP - Nepal 32
PT - Portogallo 32
JO - Giordania 31
UZ - Uzbekistan 31
JM - Giamaica 30
PE - Perù 30
TW - Taiwan 27
KE - Kenya 26
DK - Danimarca 25
DZ - Algeria 24
PY - Paraguay 24
CZ - Repubblica Ceca 22
HU - Ungheria 22
EU - Europa 21
AZ - Azerbaigian 20
BO - Bolivia 20
CR - Costa Rica 20
GR - Grecia 20
HN - Honduras 20
IL - Israele 17
UY - Uruguay 17
TT - Trinidad e Tobago 16
AL - Albania 15
LV - Lettonia 15
OM - Oman 15
LB - Libano 14
DO - Repubblica Dominicana 13
RS - Serbia 13
NI - Nicaragua 12
BY - Bielorussia 11
HR - Croazia 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
PA - Panama 10
KG - Kirghizistan 9
LU - Lussemburgo 9
CY - Cipro 8
ET - Etiopia 8
PR - Porto Rico 8
SC - Seychelles 8
SV - El Salvador 8
GT - Guatemala 7
KW - Kuwait 7
MD - Moldavia 7
QA - Qatar 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
BB - Barbados 5
KZ - Kazakistan 5
Totale 77.506
Salva come PNG Salva come JPEG
Città #
Singapore 3.146
Santa Clara 3.068
Southend 2.843
Ashburn 2.777
Fairfield 2.497
Hong Kong 1.727
Chandler 1.403
Woodbridge 1.393
Hefei 1.383
San Jose 1.320
Milan 1.195
Houston 1.163
Rome 1.053
Jacksonville 947
Council Bluffs 926
Seattle 894
Wilmington 893
Chicago 890
Los Angeles 801
Cambridge 784
Ann Arbor 783
London 735
Nyköping 687
Dearborn 669
Beijing 640
Helsinki 633
The Dalles 494
Seoul 476
Ho Chi Minh City 437
New York 412
Salt Lake City 403
Modena 379
Hanoi 377
Bologna 275
Naples 267
San Diego 264
Florence 263
Dallas 247
Izmir 244
Princeton 234
Sofia 234
Turin 214
Buffalo 213
Lauterbourg 211
Jakarta 198
Palermo 195
Redwood City 190
Moscow 186
Bari 185
Eugene 182
Tampa 175
Columbus 169
Shanghai 164
Elk Grove Village 162
Tokyo 160
Dublin 154
São Paulo 154
Genoa 148
Des Moines 141
Frankfurt am Main 136
Catania 127
Verona 126
Bremen 112
Boardman 107
Cagliari 104
Padova 99
Toronto 94
Orem 93
Falls Church 92
Sterling 88
Da Nang 84
Mexico City 81
Atlanta 80
Brescia 77
Munich 76
Phoenix 74
Guangzhou 73
Lancaster 72
Brooklyn 71
Manchester 68
Parma 67
Montreal 65
Kent 63
Detroit 60
Miami 59
Warsaw 57
Haiphong 56
Chennai 55
Redondo Beach 55
Denver 53
Monza 53
Dulles 49
Johannesburg 49
Venice 49
Bergamo 48
Mumbai 47
Perth 47
Perugia 47
Salerno 47
San Francisco 47
Totale 46.464
Salva come PNG Salva come JPEG
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 7.008
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.881
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.379
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.341
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 968
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 809
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 788
Semeiotica dell'articolazione temporo-mandibolare 582
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 493
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 485
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 470
B-cells and mixed cryoglobulinemia 449
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 447
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 420
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 417
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 413
Validation of the classification criteria for cryoglobulinaemic vasculitis 404
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 397
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 396
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 395
Thymus alterations and systemic sclerosis 388
Heart involvement and systemic sclerosis 386
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 379
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 376
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 370
Current treatment of hepatitis C-associated rheumatic diseases. 366
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 364
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 362
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 361
Cardiac Involvement in Systemic Vasculitis 360
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 356
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 355
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 353
Aortic pulse wave velocity measurement in systemic sclerosis patients. 350
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 348
Elevated Troponin Serum Levels in Adult Onset Still's Disease 344
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 342
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 342
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 334
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 332
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 330
L-Arginine in pregnant scleroderma patients 330
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 329
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 329
Acute exacerbation of interstitial lung disease associated with rheumatic disease 329
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 328
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 327
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 324
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 324
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 324
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 322
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 321
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 315
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 315
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 315
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 314
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 311
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 306
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 305
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 305
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 305
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 303
HCV and cryoglobulinemic vasculitis. 299
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 298
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 296
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 295
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 293
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 293
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 290
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 289
Cardiovascular risk and prostanoids in systemic sclerosis 288
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 288
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 287
HCV associated cryoglobulinemic vasculitis 286
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 285
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 284
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 284
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 283
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 282
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 282
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 282
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 281
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 280
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? 278
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 278
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 278
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 278
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 275
New targeted molecular therapies for dedifferentiated thyroid cancer 273
Systemic sclerosis following human cytomegalovirus infection 267
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 267
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 264
HCV-related rheumatic manifestations and therapeutic strategies 264
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 264
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 262
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 262
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 262
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 261
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 260
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 259
Totale 46.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 286.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 286.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.884 0 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/202513.591 705 370 449 972 2.413 1.779 920 700 1.426 881 1.393 1.583
2025/202624.088 1.347 916 1.897 3.068 4.300 1.706 2.732 1.032 2.081 1.772 1.722 1.515
2026/20272.073 864 1.209 0 0 0 0 0 0 0 0 0 0
Totale 78.274